Bioscience Today

Bioscience Today Bioscience Today is a contemporary publication with the goal of making the UK Life Sciences sector a focal point for clinical research and medical innovation.

Bioscience Today (previously Bioscience Journal) is a contemporary publication with the goal of making the UK Life Sciences sector a focal point for clinical research and medical innovation. Bioscience Today is available in both print and digital formats, and is aimed towards decision makers throughout the Bioscience, Medical, Pharmaceutical and Healthcare markets. With a global appeal, its content is independent and politically unbiased, and driven by investigative journalism and expert analysis from industry leaders. Covering key aspects within its chosen industries, Bioscience Today sheds light on industry-impacting stories and reveals the major players behind the growth of the UK’s Bioscience sector.

Novel nanomaterials may protect against neurological diseases through their antioxidant abilities https://www.bioscience...
07/12/2025

Novel nanomaterials may protect against neurological diseases through their antioxidant abilities https://www.biosciencetoday.co.uk/nanoflowers-could-support-brain-health/

Novel nanomaterials may protect against neurological diseases through their antioxidant abilities. At Texas A&M AgriLife Research, a new branch of brain science is blooming at the molecular scale – with nanoflowers. A study published in The Journal of Biological Chemistry demonstrated that nanoflo...

Recent levelling-off signals a maturing sector, says Ian Lloyd, Senior Director, Citeline https://www.biosciencetoday.co...
06/12/2025

Recent levelling-off signals a maturing sector, says Ian Lloyd, Senior Director, Citeline https://www.biosciencetoday.co.uk/have-we-hit-peak-oncology-navigating-the-state-of-cancer-rd-in-2025/

Recent levelling-off signals a maturing sector, says Ian Lloyd, Senior Director, Citeline. The pharmaceutical R&D ecosystem has never been bigger. The global drug pipeline now approaches 24,713 active targets, with numbers increasing 145% from January 2010 to January 20251 – a new peak for the ind...

A team from UNIGE and HUG has shown that the side on which the first symptoms of the disease appear – left or right – in...
05/12/2025

A team from UNIGE and HUG has shown that the side on which the first symptoms of the disease appear – left or right – influences patients’ cognitive and emotional symptoms https://www.biosciencetoday.co.uk/parkinsons-how-the-affected-side-shapes-disease-course/

A team from UNIGE and HUG has shown that the side on which the first symptoms of the disease appear – left or right – influences patients’ cognitive and emotional symptoms. Parkinson’s disease often begins asymmetrically, affecting either the right or left side of the body first. Researchers...

Vidmantas Šakalys, CEO of Vital3D, offers insights on the potential applications of the technology and key limitations t...
04/12/2025

Vidmantas Šakalys, CEO of Vital3D, offers insights on the potential applications of the technology and key limitations that still need to be resolved https://www.biosciencetoday.co.uk/3d-printed-tumour-models-speed-up-cancer-drug-testing/

Vidmantas Šakalys, CEO of Vital3D, offers insights on the potential applications of the technology and key limitations that still need to be resolved. Rising global cancer cases and diagnostic backlogs are increasing demand for more accurate and efficient research tools. User-friendly bio printed 3...

A collaborative project aims to accelerate a new approach to treat the most aggressive forms of brain cancer https://www...
03/12/2025

A collaborative project aims to accelerate a new approach to treat the most aggressive forms of brain cancer https://www.biosciencetoday.co.uk/breakthrough-glioblastoma-treatments-move-closer/

A collaborative project aims to accelerate a new approach to treat the most aggressive forms of brain cancer. Medicines Discovery Catapult (MDC) and King’s College London (KCL) have been awarded £400k funding from The Brain Tumour Charity to develop a groundbreaking new approach to treat glioblas...

Gentle and rapid detachment of even delicate adherent cells https://www.biosciencetoday.co.uk/gentle-and-rapid-detachmen...
01/12/2025

Gentle and rapid detachment of even delicate adherent cells https://www.biosciencetoday.co.uk/gentle-and-rapid-detachment-of-even-delicate-adherent-cells/

Detachin™ Cell Detachment Solution from Amsbio provides a superior alternative to Trypsin/EDTA for gentle detachment of adherent cells from in vitro growth vessels. Widely cited in recent published papers1, 2, 3, 4 – Detachin™ is proven to quickly deliver gentle detachment of a wide variety of...

The National Institute for Health and Care Excellence has increased the cost-effectiveness thresholds it applies for dru...
30/11/2025

The National Institute for Health and Care Excellence has increased the cost-effectiveness thresholds it applies for drugs that qualify for their Highly Specialised Technology programme https://www.biosciencetoday.co.uk/new-nice-thresholds-good-news-for-ultra-rare-disease-drugs/

The National Institute for Health and Care Excellence (NICE), the body that determines the clinical effectiveness and economic value of new medicines, has increased the cost-effectiveness thresholds it applies for drugs that qualify for their Highly Specialised Technology (HST) programme. NICE uses....

The Longitude Prize on ALS, a new £7.5 million global challenge prize, aims to encourage and reward cutting edge AI-base...
29/11/2025

The Longitude Prize on ALS, a new £7.5 million global challenge prize, aims to encourage and reward cutting edge AI-based approaches to transform drug discovery https://www.biosciencetoday.co.uk/7-5m-global-prize-pushes-for-als-drug-treatment-breakthrough/

The Longitude Prize on ALS, a new £7.5 million global challenge prize, aims to encourage and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis), the most common form of MND (motor neurone disease). Initially, it will award £...

A team from UNIGE and the University of Pisa has designed surprisingly stable molecular assemblies, paving the way for n...
28/11/2025

A team from UNIGE and the University of Pisa has designed surprisingly stable molecular assemblies, paving the way for new drug constructs and geometrically controlled materials https://www.biosciencetoday.co.uk/a-new-architecture-at-the-heart-of-molecules/

A team from UNIGE and the University of Pisa has designed surprisingly stable molecular assemblies, paving the way for new drug constructs and geometrically controlled materials. Can you imagine a life-saving molecule whose “twin” is a deadly poison? As surprising as it may seem, this chemical r...

Scientists have unlocked new details on important ‘receptor’ proteins – promising targets for the creation of novel drug...
27/11/2025

Scientists have unlocked new details on important ‘receptor’ proteins – promising targets for the creation of novel drugs for metabolic conditions ranging from diabetes to obesity and inflammatory disorders https://www.biosciencetoday.co.uk/new-discovery-in-diabetes-and-obesity-treatment/

Scientists have unlocked new details on important ‘receptor’ proteins –promising targets for the creation of novel drugs for metabolic conditions ranging from diabetes to obesity and inflammatory disorders. The discovery – published in Nature and led by the University of Glasgow, Queens Univ...

New data reveals a 57% drop in costs when compared to Q1 (April to June) 2015/16 https://www.biosciencetoday.co.uk/signi...
26/11/2025

New data reveals a 57% drop in costs when compared to Q1 (April to June) 2015/16 https://www.biosciencetoday.co.uk/significant-decline-in-cost-of-dependency-forming-medicines-prescribed-in-england/

New data reveals a 57% drop in costs when compared to Q1 (April to June) 2015/16. Recently published NHS Business Services Authority (NHSBSA) data shows a significant reduction in the cost of dependency-forming medicines prescribed in the community, falling by 57% from Q1 (April to June) 2015/16 to....

Address

Tru Knit House
Newcastle Upon Tyne
NE16UF

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Bioscience Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Bioscience Today:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category